An Ebola epidemic in eastern DR Congo sharply widened Wednesday, the eve of the first anniversary of the outbreak, with one death and another diagnosis reported and the quarantining of 15 people in a previously unaffected ...
Jul 31, 2019
0
1
Patients with end-stage renal disease (ESRD) experience extremely high morbidity and mortality, and there are virtually no therapeutic interventions besides dialysis treatment which are proven, in properly designed randomized ...
Jun 14, 2019
0
0
When appropriate, short-interval follow-up magnetic resonance imaging (MRI) can be used to identify early stage breast cancer and avoid unnecessary biopsies, according to a study to be presented at the ARRS 2019 Annual Meeting, ...
May 7, 2019
0
1
AKR1B10 is a useful serum biomarker for advanced liver fibrosis in Nonalcoholic steatohepatitis, and combined with serum WFA(+)-M2BP, it can predict hepatocellular carcinoma development, gastroesophageal varix formation, ...
Apr 12, 2019
0
0
The first large-scale clinical trial to study liver transplantation between people with HIV has begun at clinical centers across the United States. The HOPE in Action Multicenter Liver Study will determine the safety of this ...
Feb 14, 2019
0
1
Squamous cell carcinoma is one of the most common cancers of the skin and mucosa. Treatment options for the advanced stage have been very limited for patients with tumours of the head and neck, i.e. in the mouth, the pharynx ...
Jan 17, 2019
0
0
In a 10-year study of women who received radiation therapy to treat early-stage breast cancer, those receiving fewer, larger individual doses experienced similarly low rates of late-onset side effects as those undergoing ...
Oct 29, 2018
0
0
A recent study from the Madras Diabetes Research Foundation, Chennai, India and University of Lyon, France, brings new hope for using 'liquid-biopsy' exosomal microRNA biomarkers (miRNAs) from urine to predict risk for kidney ...
Oct 29, 2018
0
4
Acute critical illness in people without previous renal disease puts them at risk of kidney complications as well as death, according to a study in published in CMAJ (Canadian Medical Association Journal).
Sep 10, 2018
0
1
A phase III randomized clinical trial of 4,088 women with HER2-positive, early-stage breast cancer found that taking trastuzumab (Herceptin) for 6 months was non-inferior to the current standard of 12 months. The disease-free ...
May 17, 2018
0
4
